Company record
ANP Technologies, Inc. specializes in producing immunogenetic assay supplies and home‑or point‑of‑care diagnostic platforms that are built on proprietary, patented nanobiomaterials. Its portfolio comprises immunogenicity assay kits, a range of diagnostic reagents and test kits, as well as immunoassay diluents. These offerings support diverse applications such as drug‑delivery formulations, swift detection of biological‑warfare agents, immunogenicity assessments, rapid medical diagnostics, and various bioanalytical methods and assay components. The firm primarily serves the nanobiotechnology sector and the biodefense market.
This directory record does not yet have a linked material-flow brief.